Senior insider sale
Chief Executive Officer at APOGEE THERAPEUTICS, INC. — senior position signals high conviction
$15.56M
140K shares
What this filing means
HENDERSON MICHAEL THOMAS plans to sell 140K shares of APOGEE THERAPEUTICS, INC. valued at approximately $15.56M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/22/2026ACC: 0001949846-26-000395
DirectorOfficer· Chief Executive Officer
Since Feb 2026
140K
Shares to sell
$15.56M
Approx. market value
80K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
VESTING RSU's
NA
5/2/2023
80KTotal acquired80K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/2/2023 | VESTING RSU's NA | 80K | — |
| Total | 80K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
20K
Market value
$1.67M
6/10/2026
—Completed
Units to sell
20K
Market value
$1.64M
5/13/2026
—Completed
Units to sell
20K
Market value
$1.65M
4/8/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
80K
Market value
$10.60M
6/22/2026
Total
Units
140K
Value
$15.56M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/10/2026 | 20K | $1.67M | — | Completed |
5/13/2026 | 20K | $1.64M | — | Completed |
4/8/2026 | 20K | $1.65M | — | Completed |
| Planned — Approximate Date | ||||
6/22/2026 | 80K | $10.60M | NASDAQ | Planned |
| Total | 140K | $15.56M | ||